The peptide timeline guide covers expected response curves for specific compounds
doi:10.1371/journal.pone.0162590.g010 Diclofenac, L-NAME, L-Arginine and BPC 157 in Short-Bowel Rats PLOS ONE | DOI:10.1371/journal.pone.0162590 September 14, 2016 14 / 18 Finally, the differential beneficial effects of BPC 157 (COX and NOS blockade), L-arginine (NOS-blockade), and L-arginine-independent BPC 157 effects, might support the proposition that BPC 157 and L-arginine may act via two separate NO system pathways as previously sug- gested [3]
PMCID: PMC8116695
Enhancement of synaptic plasticity and reversal of impairments in motor and cognitive functions in a mouse model of Angelman Syndrome by a small neurogenic molecule, NSI-189
If this is not the case, it may compromise care and result in inadequate removal of the tattoo pigment or even scarring
Our team at Real Peptides understands this better than anyone